VantagePoint Capital Partners — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Genomaticagenomatica.comin 𝕏May 2021

Genomatica (Geno) develops biotechnology processes to produce bio-based chemicals and materials—such as 1,4-butanediol (BDO), butylene glycol for cosmetics, and plant-based nylon—as alternatives to fossil-fuel-derived inputs.

BiotechCircular EconomyCleantechClimate TechNew MaterialsSan Diego, US

Rasmus von Gottberg(Executive Officer)Thomas McDonald(Executive Officer)Christophe Schilling(Co-founder (former CEO))Craig Binetti(Director)David Muldoon(Executive Officer)Jason Kelly(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.